Del Re, M.; Vivaldi, C.; Rofi, E.; Salani, F.; Crucitta, S.; Catanese, S.; Fontanelli, L.; Massa, V.; Cucchiara, F.; Fornaro, L.;
et al. Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer. Cancers 2021, 13, 3738.
https://doi.org/10.3390/cancers13153738
AMA Style
Del Re M, Vivaldi C, Rofi E, Salani F, Crucitta S, Catanese S, Fontanelli L, Massa V, Cucchiara F, Fornaro L,
et al. Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer. Cancers. 2021; 13(15):3738.
https://doi.org/10.3390/cancers13153738
Chicago/Turabian Style
Del Re, Marzia, Caterina Vivaldi, Eleonora Rofi, Francesca Salani, Stefania Crucitta, Silvia Catanese, Lorenzo Fontanelli, Valentina Massa, Federico Cucchiara, Lorenzo Fornaro,
and et al. 2021. "Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer" Cancers 13, no. 15: 3738.
https://doi.org/10.3390/cancers13153738
APA Style
Del Re, M., Vivaldi, C., Rofi, E., Salani, F., Crucitta, S., Catanese, S., Fontanelli, L., Massa, V., Cucchiara, F., Fornaro, L., Capuano, A., Fogli, S., Vasile, E., & Danesi, R.
(2021). Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer. Cancers, 13(15), 3738.
https://doi.org/10.3390/cancers13153738
